Speakers

Erik Buntinx

CEO, PharmaNeuroBoost

Keynote: Keynote Talk II - 11:45 AM

Dr. Erik Buntinx, °1962, MD - Psychiatrist is Chief Executive Officer, Chief Scientific Officer and Managing Director.

He is an experienced psychiatrist who founded Anima Center, one of the largest outpatient psychiatric clinics with an integrated clinical research unit in Belgium and was former advisor of the WHO. He has developed knowledge database and patient management software.

Dr. Erik Buntinx has been Principal Investigator for various Phase IIa-III Clinical Trials for which he observed approximately 250 patients in total. He was involved in programs on Risperidone, Mianserine, Cycloserine, Sertraline, Asenapine, Agomelatine, Escitalopram, Gaboxadol and several NK1-Antagonists and developer of Investigator Initiated Trials in Delirium and authority in CNS Drug Development. As such he is a frequently invited moderator and speaker at various B2B conferences and workshops.

Finally, he is the inventor of PNB's IP on the use of high selective 5HT-2A/D4 Antagonists. He obtained his MD degree from the Catholic University of Leuven (KUL), Belgium and com- pleted his psychiatric residency at the KUL and the University of Maastricht, The Netherlands.